In HIV positive patient with pneumocystis jiroveci infection, which of the following is used for prevention?: (A) Azithromycin, (B) Acyclovir, (C) C. Levofloxacin, (D) Sulfomethoxazole+ trimethoprim
Answer is D. Ans. (d) Sulfomethoxazole and trimethoprimRef: Harrison 19th ed. / 492* Prophylaxis with trimethoprim-sulfamethoxazole (TMPSMZ) prevents many opportunistic infections, including infection with P. carinii, Toxoplasma gondii, and community-acquired respiratory, gastrointestinal, and urinary tract pathogens.* Intolerance of TMP-SMZ is common; desensitization is useful less often in transplant patients than in patients with AIDS. Alternative agents provide a narrower spectrum of protection than does TMP-SMZ and less adequate protection against Pneumocystis species